© 2022 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.
PDT/HAL delivers rejuvenation without significant downtime
A randomized, split-face, controlled study has shown that photodynamic treatment using hexyl aminolevulinate HCl (HAL; Allumera, Photocure) and multiple laser and light sources is safe, well tolerated and effective for photorejuvenation, says Sabrina Fabi, M.D.
Key Points
La Jolla, Calif. - A randomized, split-face, controlled study has shown that photodynamic treatment using hexyl aminolevulinate HCl (HAL; Allumera, Photocure) and multiple laser and light sources is safe, well tolerated and effective for photorejuvenation, says Sabrina Fabi, M.D.
The hexyl aminolevulinate study enrolled 21 patients with moderate-to-severe photoaging, and all but one completed the trial that involved three treatment sessions and a final evaluation at one month after the last treatment. The enrolled patients had a mean age of 52 years, Fitzpatrick skin types II-IV and were nearly all women.